These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29438429)

  • 1. Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries.
    Davis K; Gorst SL; Harman N; Smith V; Gargon E; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS One; 2018; 13(2):e0190695. PubMed ID: 29438429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey.
    Gorst SL; Gargon E; Clarke M; Blazeby JM; Altman DG; Williamson PR
    PLoS One; 2016; 11(1):e0146444. PubMed ID: 26785121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing important health outcomes for comparative effectiveness research: a systematic review.
    Gargon E; Gurung B; Medley N; Altman DG; Blazeby JM; Clarke M; Williamson PR
    PLoS One; 2014; 9(6):e99111. PubMed ID: 24932522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps.
    Gorst SL; Gargon E; Clarke M; Smith V; Williamson PR
    PLoS One; 2016; 11(12):e0168403. PubMed ID: 27973622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing important health outcomes for comparative effectiveness research: 4th annual update to a systematic review of core outcome sets for research.
    Gargon E; Gorst SL; Harman NL; Smith V; Matvienko-Sikar K; Williamson PR
    PLoS One; 2018; 13(12):e0209869. PubMed ID: 30592741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion of participants from low-income and middle-income countries in core outcome sets development: a systematic review.
    Karumbi J; Gorst SL; Gathara D; Gargon E; Young B; Williamson PR
    BMJ Open; 2021 Oct; 11(10):e049981. PubMed ID: 34667005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing important health outcomes for comparative effectiveness research: 5th annual update to a systematic review of core outcome sets for research.
    Gargon E; Gorst SL; Williamson PR
    PLoS One; 2019; 14(12):e0225980. PubMed ID: 31830081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of international Delphi surveys for core outcome set development: representation of international patients.
    Lee A; Davies A; Young AE
    BMJ Open; 2020 Nov; 10(11):e040223. PubMed ID: 33234639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for research.
    Gargon E; Gorst SL; Matvienko-Sikar K; Williamson PR
    PLoS One; 2021; 16(1):e0244878. PubMed ID: 33434219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient participation impacts outcome domain selection in core outcome sets for research: an updated systematic review.
    Dodd S; Gorst SL; Young A; Lucas SW; Williamson PR
    J Clin Epidemiol; 2023 Jun; 158():127-133. PubMed ID: 37054902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A scoping review of core outcome sets and their 'mapping' onto real-world data using prostate cancer as a case study.
    Meregaglia M; Ciani O; Banks H; Salcher-Konrad M; Carney C; Jayawardana S; Williamson P; Fattore G
    BMC Med Res Methodol; 2020 Feb; 20(1):41. PubMed ID: 32103725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Outcome Set-STAndards for Development: The COS-STAD recommendations.
    Kirkham JJ; Davis K; Altman DG; Blazeby JM; Clarke M; Tunis S; Williamson PR
    PLoS Med; 2017 Nov; 14(11):e1002447. PubMed ID: 29145404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a core outcome set for effectiveness trials aimed at optimising prescribing in older adults in care homes.
    Millar AN; Daffu-O'Reilly A; Hughes CM; Alldred DP; Barton G; Bond CM; Desborough JA; Myint PK; Holland R; Poland FM; Wright D;
    Trials; 2017 Apr; 18(1):175. PubMed ID: 28403876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey.
    Li G; Zhou L; Ouyang W; Xuan M; Lu L; Li X; Wen Z; Chen X
    Trials; 2019 Jan; 20(1):14. PubMed ID: 30612586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
    Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
    Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.
    Potter BK; Hutton B; Clifford TJ; Pallone N; Smith M; Stockler S; Chakraborty P; Barbeau P; Garritty CM; Pugliese M; Rahman A; Skidmore B; Tessier L; Tingley K; Coyle D; Greenberg CR; Korngut L; MacKenzie A; Mitchell JJ; Nicholls S; Offringa M; Schulze A; Taljaard M;
    Trials; 2017 Dec; 18(1):603. PubMed ID: 29258568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary analysis of data from a core outcome set for burns demonstrated the need for involvement of lower income countries.
    Davies PA; Davies AK; Kirkham JJ; Young AE
    J Clin Epidemiol; 2022 Apr; 144():56-71. PubMed ID: 34906674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.